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1. INTRODUCTION  
1.1. Physiological characteristics of infancy and small childhood 
Because of their wide-ranging immaturity, prematures, term neonates and infants may 
undoubtedly be considered the most vulnerable population of patients. This period of life 
can be characterized by overall unsteadiness, with sudden and unusual reactions to 
different stimuli. Their reduced reserves and limited compensatory mechanisms, 
accompanied by their increased and altered reflex activity, predispose them to undergo 
rapid changes in their condition. This physiologically unstable state may be coupled with 
various diseases and/or special age-related diseases, such as congenital defects, necrotizing 
enterocolitis (NEC), the respiratory distress syndrome (RDS) or neonatal sepsis. In certain 
cases, they cannot be treated by conservative therapy, and surgical interventions may be 
required. The younger the patient, the higher is the risk of cardiovascular complications 
during anaesthesia and surgery (1, 2). 
In spite of its immaturity at birth and the dynamic changes that occur throughout the 
further development of the patient, the cardiovascular system (in close conjunction with 
the respiratory system) forms a dynamic to-and-fro metabolic passage between the cells 
and the environment. A blood supply deterioration caused by hypovolaemia, sepsis or 
shock results in an early rearrangement of the circulation, diverting the blood flow from 
the splanchnic region towards organs of vital importance. During the recovery period, the 
splanchnic circulation is the last to be restored (3, 4).  
In view of the possible very rapid changes in the condition of these patients, there is a need 
for a reliable, not very expensive, complication-free, non-invasive and reproducible 
monitoring method with which to be able to follow the changes in their status and to 
predict the outcome of the disease. Monitoring should be started as early as possible and 
should be continued as long as required. 
Apart from the discrepancies caused by the different sizes of the patients and tonometric 
probes currently available, gastrotonometry or gastric tonometry could meet these 
requirements (5, 6). Boda et al. recently developed a balloon-free new generation of gastric 
tonometric sampling probes which can be applied even in the smallest population of 
patients (7). Gastric tonometry has proved to be a simple, sensitive, organ-specific and 
early detector of the condition of the splanchnic circulation and the oxygenation of the 
gastrointestinal organs. Deterioration of the gastrointestinal blood flow can be the first sign 
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of an insufficiency of the systemic circulation. Splanchnic vasoconstriction is part of the 
redistribution process of the systemic circulation in response to generalized stress stimuli. 
In consequence of a reduction of tissue oxygenation, cellular anaerobic metabolism results 
in the excessive production of carbon dioxide (CO2) in the gastrointestinal mucosa. 
Measurement of the intragastric partial pressure of CO2 (PgCO2) and calculation of its 
difference from the arterial partial pressure of CO2 (PaCO2) may provide valuable 
information concerning the metabolic and circulatory conditions of the stomach and the 
splanchnic region. 
In our studies, we set out to examine the feasibility and reliability of the new neonatal 
probes under paediatric surgical conditions and on critically ill, ventilated patients in the 
neonatal intensive care unit (NICU). Furthermore, we compared the Pg-aCO2 gap (the 
difference of PgCO2 and PaCO2) with the Pg-ETCO2 gap (the difference of PgCO2 and 
PETCO2, the end-tidal partial pressure of CO2), as an alternative, and investigated the 
relationship between increased Pg-ETCO2 gap values and an unfavourable outcome. 
 
1.2. Characteristics of CO2 in the human body 
1.2.1. Metabolism and role of CO2 in the human body 
CO2 is a final product of great importance in the cellular metabolism. During the aerobic 
metabolism, the mitochondria consume oxygen (O2) and produce CO2. CO2 diffuses from 
the mitochondria into the cellular cytoplasm, crosses the cell membrane and travels into the 
blood flow.  
There are four types of CO2 transport in the blood (8):  
 That of the amount of physically dissolved CO2 (5%), which can be calculated via 
Henry’s law, and accounts for the partial pressure of CO2 in the blood (PCO2). Its level 
increases linearly with increases in PCO2. Changes in temperature can modify the 
solubility of CO2 in the blood and hence PCO2.  
 Nearly 5% of the blood CO2 is transported in the form of carbamino compounds, as 
CO2 binds reversibly to the non-ionized terminal amino (-NH2) groups of blood-borne 
proteins and haemoglobin (Hb). Following a concentration gradient into the red cells, a 
small fraction remains dissolved in the cytoplasm and some is loosely bound to -NH2 
groups of reduced Hb forming carbamino-Hb. 
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 Some of the dissolved CO2 reacts with water, and rapidly undergo hydration to form 
carbonic acid (H2CO3) through the action of the enzyme carbonic anhydrase. H2CO3 
immediately dissociates to the bicarbonate ion (HCO3
-
) and a hydrogen ion (H
+
).  
CO2 + H2O    H2CO3   H
+
 + HCO3
-
 
This reaction is slow in the plasma, but more than 10 000 times faster in the 
erythrocytes. HCO3
-
 diffuses out of the erythrocytes into the plasma according to the 
law of mass action. Nearly 90% of the total CO2 content is transported in the form of 
HCO3
 - 
: 65% by the plasma, and the remaining 25% by red cells. 
 A negligible amount (less than 0.1%) of CO2 is transported as H2CO3
-
. 
Three parameters of the blood CO2 content can be determined in routine practice by blood 
gas analysis: PCO2, the plasma concentration of HCO3
-
 and the total concentration of CO2 
in the plasma (ctCO2). 
Of these, only PCO2 is actually measured during blood gas analysis; the other two 
parameters are calculated from the blood pH and PCO2.  HCO3
- 
, PCO2 and pH are the 
main determinants of the acid-base status. 
The blood pH and ctCO2 in the plasma or serum can be measured by chemical methods. 
CO2 has multiple roles of in the human body: 
 It is regulator of breathing. 
 It is a relaxant of the vascular smooth muscles and a regulator of vascular resistance 
(and hence the blood flow of the organs). 
 It plays an important role in the acid-base balance. 
 It is a regulator of the O2 affinity of haemoglobin via the Bohr - effect. 
 CO2 is presumed to act as a signalling molecule in various physiological processes, 
such as the control of blood flow, breathing, hearing and reproduction (9). 
 
The redundant CO2 is exhaled by the lungs and the gastric mucosa or excreted with the 
urine and stools in the form of HCO3
- 
. The theory of gastric ventilation (10) postulates 
that, with regard to the common embryological origin, the anatomical-functional 
similarities (large internalized surface areas and direct communication with the external 
environment of the body) and the shared and communicating innervation of the respiratory 
and gastrointestinal systems, the stomach plays a supplementary ventilation-like role in the 
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process of CO2 elimination. The importance of gastric ventilation has been proved during 
digestion in the normocapnic state, in non-deglutitive respiratory acidosis and in non-
deglutitive metabolic acidosis (10).  
 
1.2.2. Formation of CO2 in the gastric lumen 
As a result of the accumulation of CO2 in the bloodstream, hypercapnic acidosis develops 
and the nucleus tractus solitarius receives input from the central chemoreceptors (such as 
the retrotrapezoid nucleus, ventrolateral medulla, rostroventrolateral medulla, medullary 
raphe, locus coeruleus, fastigial nucleus and lateral hypothalamus), from the peripheral 
chemo- and baroreceptors and from a variety of airway receptors. The caudal solitary 
complex maintains several ventilatory-cardiovascular and gastrointestinal functions under 
integrative control and finally, as a vagus-mediated reflex mechanism, it enhances the 
development of changes in the respiratory rhythmogenesis and ventilatory pattern 
formation and in the cardiovascular output, and gives rise to an increased gastric mucosal 
blood flow and the increased production of gastric juice and HCO3
-
 (10).  
Arterialized blood rich in CO2 supplies the stomach and, according to the law of mass 
action, CO2 from the blood crosses the basolateral membrane by diffusion to the gastric 
epithelium. This process is enhanced by an increased gastric blood flow. Inside the 
epithelial cells, CO2 reacts with water to form H2CO3. A certain amount of H2CO3 quickly 
dissociates into H
+
 and HCO3
-
, generating a steady-state condition. Some of the 
intracellularly formed HCO3
-
 then returns to the gastric circulation in exchange for Cl
-
 in 
order to decrease respiratory acidosis, and the remaining HCO3
-
 crosses the apical 
membrane and enters the gastric lumen to neutralize the intraluminal H
+
 in the canaliculi 
and gastric mucosa, resulting in the regeneration of CO2.  In contrast with its passage into 
the gastric lumen, the gastric mucosa is impermeable to CO2, preventing its diffusion back 
from the intragastric space, especially during gastric acid secretion (10, 11). 
In the case of an acid-base balance and in the absence of food stimuli, the production of 
CO2 and gastric acid is minimal, but a significant amount of CO2 is generated after meals 
or in the event of an acid-base imbalance (10, 11). 
The CO2 required for the production of gastric acid, and hence the intragastric mucosal 
CO2, is mostly supplied by the blood, transported largely as HCO3
-
 and to a lesser extent as 
carbamino compounds, but the volume of physically dissolved CO2 (which sets PaCO2) is 
also noteworthy. The results of gastric tonometric studies demonstrate a close correlation 
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between PaCO2 and the gastric mucosal tissue PCO2 during alveolar hyperventilation and 
hypoventilation in humans (12 - 14).  
 
1.3. Measurement of gastric CO2 
1.3.1. Basic considerations of gastric tonometry 
Gastrointestinal luminal PCO2 tonometry is a method of measuring the mucosal PCO2 and 
thereby the adequacy of the local tissue oxygenation in the hollow organs of the 
gastrointestinal tract. During its long history, tonometry has been performed in different 
parts of the gut, such as the sublingual region, the oesophagus, the stomach, the bowel and 
the sigma. Of these, gastric tonometry proved to be the easiest and most practical way of 
gaining reliable and sensitive information about the adequacy of oxygenation in the 
stomach mucosa and hence the condition of the systemic and splanchnic circulations. The 
theory that fluid inside a hollow organ approximates the gas tension in the surrounding 
tissues was first proposed by Dawson and his colleagues, but the publications relating to 
the method of gastrotonometry in the late 1950s are strongly linked with the name of the 
paediatrician Boda and his research fellow Murányi (12), and Boda and his colleagues 
subsequently made a number of significant contributions (6, 7, 15 - 21). In 1995, Fiddian - 
Green and his colleagues revised the concept of gastrotonometry (22).  During recent 
decades, both the tools and the method have undergone a number of changes and the 
procedure is generally referred to in the literature under the name gastric tonometry. 
In a state of adequate oxygenation, mitochondrial oxidative phosphorylation is able to 
produce sufficient adenosine triphosphate (ATP) for the metabolism of the cells. During 
hypoxia, the only possibility for energy production is the unsatisfactory anaerobic 
glycolysis. A pathological condition develops, irreversible ATP hydrolysis, when the 
hydrolysis of ATP exceeds the rate of ATP synthesis. 
2 ATP → 2 ADP + 2 H+ + Pi + energy 
where ADP = adenosine diphosphate and Pi = phosphate ion. 
As an end-product of the process, H
+ 
accumulates and provokes acidosis. The H
+ 
formed is 
buffered by tissue HCO3
-
 resulting in excessive gastric CO2 production. 
Because of the lack of other compensatory blood vessels, this mechanism can be detected 
the earliest in the intestinal villi supplied with blood by only one end-artery. Intestinal 
mucosa lies over the end-point of this arteriola where the partial pressure of O2 (PO2) and 
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the O2 gradient are the smallest, and the intestinal mucosa can therefore be considered the 
most sensitive indicator of tissue hypoxia. 
In shock conditions, as part of the redistribution of the circulation, early selective 
vasoconstriction of the splanchnic area in order to enhance the blood supply of the most 
important organs can be observed. The oesophagus and the sublingual regions are not 
supplied by the splanchnic blood vessels, and unlike the stomach or the bowels, cannot be 
thought of as sensitive early indicators of deterioration of the systemic circulation. 
The method of gastric tonometry is based on the fact that the CO2 content in the superficial 
layers of the mucosa equilibrates with the CO2 in the lumen of the gut, which can therefore 
be deduced from it. A gastric catheter combined with a silicone tonometric balloon 
permeable to CO2 is inserted into the lumen of the gut in the same way as a standard 
nasogastric probe. The balloon is then filled with air (23). After a certain equilibration 
time, the content of the balloon is sucked out and its PCO2 (which reflects the PCO2 of the 
mucosa) can be determined (23). Normal saline, gastric acid or buffered solutions injected 
anaerobically can be applied to fill the balloon instead of air (24, 25) (see Fig. 1).  
 
Figure 1    Principles of PCO2 and HCO3
- 
diffusion in gastric tonometry  
(Original picture: Stomach mucosal layer labeled.svg. Commons.wikimedia. 
http://commons.wikimedia.org/wiki/File:Stomach_mucosal_layer_labeled.svg)
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1.3.2. Evaluation of gastric tonometric variables  
From the measured intragastric PCO2, the gastric intramucosal pH (pHi) can be calculated 
via the Henderson – Hasselbalch - equation, with the assumption that the HCO3
-
concentration of the gastric mucosa is equals to the systemic arterial HCO3
-
 level, which 
holds true except for pathologic states involving partial or total gastric ischaemia. 
pHi = 6.1 + log ___ 
[HCO3
-
]____                           
where pHi is gastric intramucosal pH, 
6.1 is the pKa of CO2 ,  
HCO3
-
  is the gastric intramucosal HCO3
-
 concentration (≈ arterial HCO3
-
 concentration), 
PCO2  is the gastric intraluminal PCO2 measured by gastric tonometry, 
α is a constant representing the solubility of CO2 in the plasma (= 0.03), and 
F(SS) is a corrective factor proportional to the equilibrium time (26, 27).
 
Since pHi is affected by both the splanchnic O2 supply and the systemic acid-base 
conditions, pHi can be regarded as a sensitive and early predictor of the patient outcome. 
In order to avoid possible bias caused by the use of arterial HCO3
-
 (for the calculation of 
mucosal pH, Fiddian - Green recommends the introduction of the use of a standard pH and 
the pH gap (22).  In this manner, the effects of changes in the acid-base balance on the 
mucosal pH can be eliminated.  
Local hypoxia can be differentiated from generalized acidosis through use of a standard 
pHi instead of the actually determined pHi: 
Standard pHi = 7.4 -  tonometer  PCO2       (normally =  7.4 ± 0.04) (28) 
In order to be able to make further distinctions between local hypoxia and generalized 
acidosis on the basis of the results of gastric tonometry, another parameter, the PCO2 gap, 
i.e. the difference between the tonometric and arterial PCO2, can be introduced. Studies on 
normal volunteers suggest that its acceptable value is 1 kPa. On the assumption that the 
PaCO2 – alveolar PCO2 difference is constant (normally 4 mmHg = 0.5 kPa), the Pg–ETCO2 
gap, a minimally invasive marker of gastric perfusion (normal values up to 1.5 kPa) can 
also be applied during evaluation of the tonometric findings (29). Use of the Pg–ETCO2 gap 
instead of Pg–aCO2 gap  makes  arterial  blood  gas analyses unnecessary. Widening of the  
 PCO2 x α x F(SS) 
PaCO2    
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Pg–ETCO2 gap is indicative of an increasing ventilation/perfusion imbalance. Normal values 
of CO2 gaps do not necessarily mean healthy states. In the follow-up of the patients' 
conditions, the changes in their trends can be much more valuable than the actual 
numerical values. Furthermore, CO2 gaps should always be considered in conjunction with 
other clinical findings. Negative CO2 gaps can be caused either by equipment failure or by 
the presence of surplus gastric air. 
Numerous studies have supported the reliable application of gastric tonometry in different 
fields of medicine: 
 Intensive care (sepsis, shock, multiple organ failure, weaning from a ventilator) (26, 
27, 30 - 33) 
 Anaesthesiology (34, 35) 
 Traumatology (36, 37) 
 Neurology (38) 
 Nephrology (39) 
 Cardiology, cardiac surgery (40 - 42) 
 Liver transplantation (43, 44) 
 Vascular surgery (29) 
 Abdominal surgery (45) 
 Abdominal compartment syndrome (46) 
 Gastroenterology (29, 47 - 48) 
 Clinical investigations on the pharmacological effects of drugs (27, 29, 49) 
 Paediatrics and neonatology (50 - 52) 
 Major burns (53) 
 
Benefits of gastric tonometry: 
 It is a simple and a relatively non-invasive / semi-invasive method. 
 It is free from local tissue artifacts caused by electrode insertion.  
 It does not require sensors that can suffer drift or need in vivo recalibration. 
 It provides an organ-specific measure of hypoxia. 
 Detection of local tissue hypoxia is possible within minutes. 
 It provides predictive information concerning complications and the outcome of the 
patient’s condition. 
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 It provides a possibility for early, more appropriate and more effective interventional 
measures, the control of their effectiveness and a valuable end-point for resuscitation. 
 It eliminates the need for more expensive forms of monitoring. 
 It shortens the length of the hospital stay (54).  
 It reduces the costs of intensive care (54). 
 
Possible sources of bias during gastric tonometry: 
 Incorrect positioning (the catheter is not in the stomach or it is positioned too close to 
the pylorus). 
 The influence of the traditionally administered H2-receptor antagonists on the 
reliability of the measurement is controversial (10, 11, 55).  
 The swallowing of air, and the entry of air into the stomach, mostly in spontaneously 
ventilating, non-intubated patients or those undergoing nasogastric suction may result 
in a transient lowering of the gastric PCO2 (11). 
 An adequate equilibration time must be ensured. Adoption of a corrective factor 
proportional to the equilibration time (based on experimental data) during the 
evaluation of gastric tonometric variables allows the use of shorter equilibration times 
(27). 
 The catheter dead-space should be taken into account. With the help of appropriately 
prolonged dwell times, the diluting effect of a larger deadpace can be nearly eliminated 
(56). 
 The evaluation is based on the assumption that the HCO3
-
 concentration in the gastric 
mucosa is equal to the systemic arterial HCO3
-
 concentration, though this may not be 
valid in shock (57, 58). 
 PaCO2 must be corrected for body temperature. 
 A pressure correction can eliminate the influence of the atmospheric pressure and the 
pressure exerted by the adjacent anatomical structures on PCO2 in the gaseous phase. 
 The molecular weight of Nitrous oxide (N2O) is equal to that of CO2, and simultaneous 
direct measurement of both gases should therefore be performed. 
 Technical errors may appear if examination samples are not handled with the necessary 
care. 
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1.3.3. Gastric tonometry in childhood  
There is an extensive literature on the applications of gastric tonometry in adults, but the 
number of studies on children is appreciably less. This can mostly be explained by the 
technical limitations caused by the different sizes of the patients and the tools available. 
Nevertheless, trials of the method in critically ill children (51), anaesthetized paediatric 
cases during and after surgery (52), neonates (59) and even very low birth weight infants 
(50) have been published. The limited data available in this field support the predictive 
value and clinical usefulness of gastric tonometry in a heterogeneous paediatric population. 
In order to evaluate the gastric tonometric data obtained in paediatric patients, reference 
values in children are necessary. Reinoso – Barbero et al. found that the normal range of 
the pHi in normoventilated and haemodynamically stable children in the age range 6 
months to 12 years, who had not been previously treated with ranitidine under minor 
reconstructive surgery, was 7.35 ± 0.06 (60).  
Authors of studies on paediatric tonometry share the unanimous opinion that pHi is a 
reliable, highly specific and sensitive early predictor of haemodynamic complications and 
early mortality in the paediatric population. The relative safety, simplicity and semi-
invasive character of the method make it especially suitable for routine use in the critically 
ill paediatric age group, more invasive and complicated methods being reserved for use 
with special indications. In order to be able to detect the deterioration of splanchnic tissue 
oxygenation as early as possible, regular measurements on a 4 h basis are advised, unless 
continuous measurement is available (51, 52).  The use of tonometric catheters is generally 
free of any major complications (epistaxis may sometimes occur). 
Several studies support the applicability of blood samples obtained either from veins or 
capillaries for the determination of the systemic acid-base status, involving the pH, PCO2, 
HCO3
-
 and base excess (BE) in paediatric patients of different ages. These results correlate 
well even in patients in poor condition. Venous or arterialized capillary blood gas analyses 
can therefore be useful alternatives of painful and sometimes complicated arterial blood 
sampling for arterial blood gas measurements in children (61). 
Many authors dealing with gastric tonometry highlight the importance of the method in 
paediatric care (50, 59). The new Boda’s gastric tonometric probe was developed to meet 
the demand for a tonometric catheter with rapid equilibration and ready applicability in 
patients of all ages, including very low birth weight neonates (16). 
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2. AIMS AND QUESTIONS OF THE STUDIES 
The usefulness of the novel gastric tonometric probe in paediatric patients has already been 
proven by earlier studies (7, 15 - 19). We designed two prospective clinical investigations 
in order to support the applicability and reliability of the new neonatal gastric tonometric 
tool in extended fields: in the paediatric population under intraoperative conditions (study 
1), and in low birth weight NICU patients in critical states (study 2).  
We were the first to apply the novel gastric tonometric probe in this age group during 
surgical procedures. We wished to exploit the known benefits of the method: to assess the 
adequacy of ventilation and the splanchnic perfusion of the patients and to acquire 
information as to the severity of the disease.   
We investigated the possibility of gaining therapeutic information in a semi-invasive 
manner, bypassing the risk of infection and vasoconstriction caused by the painful and 
often difficult blood sampling, and the considerable anaemia and haemodynamic changes 
that can occur in these small patients due to the significant blood loss caused by repeated 
blood samplings. In order to reduce the need for repeated blood sampling, we set out to 
examine and the possible usefulness of the Pg-ETCO2 gap by using capnometric PETCO2 
values instead of PaCO2. We are not aware of previous studies of the diagnostic value of   
the Pg-ETCO2 gap in this age group.  
Both studies were approved by the Human Investigation Review Board of the University 
of Szeged. In every case, informed consent was obtained from the parents.  
The main questions studied were the following: 
Question I 
Can the novel gastric tonometric probe developed for paediatric patients of all ages be used 
safely and reliably during paediatric surgical procedures (study 1) and in the population of 
smallest paediatric patients in the NICU (study 2)?  
Question II 
Is there any difference between the groups in terms of the PETCO2 values during surgery 
(study 1) and in NICU patients (study 2)? 
Question III 
Is there any correlation between the PaCO2 and PETCO2 values in the examined patients 
during surgery (study 1) and in NICU patients (study 2)?  
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Question IV 
Does the respiratory dead-space of the patients exert any effect on the Pg-ETCO2 gap? 
Question V 
Is there any difference between the groups in terms of the PgCO2 values during surgery 
(study 1) and in NICU patients (study 2)? 
Question VI 
Is there any difference between the groups in terms of the Pg-aCO2 gap values during 
surgery (study 1) and in NICU patients (study 2)? 
Question VII 
Is there any difference between the groups in terms of the Pg-ETCO2 gap values during 
surgery (study 1) and in NICU patients (study 2)? 
Question VIII 
Is there any correlation between the Pg-aCO2 and Pg-ETCO2 gaps during surgery (study 1) 
and in NICU patients (study 2)? 
Question IX 
Does the Pg-ETCO2 gap relate to the severity of the disease? 
 
3. STUDY 1 
Study no. 1 was a prospective randomized study of the therapeutic value of the Pg-ETCO2 
gap beyond the already proven clinical reliability of the Boda probe under intraoperative 
circumstances in paediatric patients. 
 
3.1. Patients  
The prospective study enrolled a total of 25 anaesthetized surgical patients: 19 elective and 
6 acute cases. The 19 elective surgical patients were assigned to one or other of two groups 
according to their ages (group I and group II). Group III consisted of the acute surgical 
patients, independently of their ages. The patient characteristics, the diagnoses and the 
compositions of the groups are presented in Table 1.  
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Table 1 Characteristics of the three groups of cases involved in the study 
 
Parameters  Group I 
(elective surgery 
group < 2 years 
old, n = 10) 
Group II 
(elective surgery 
group > 2 years 
old, n = 9) 
Group III 
(acute surgery 
group, 
n = 6) 
Age (months)  
Median and Range 
11.2 
0.1 - 24 
97.7 
29 - 261 
98 
15 - 204 
Weight (kg)   
Median and Range 
7.3 
3.0 - 15 
26.6 
25 - 261 
27.4 
28 - 193 
Diagnosis 
 
Hydronephrosis (4) 
Hypospadia 
Ovarial cyst  
Duodenal atresia 
Nephrectomy 
Port-a-cath 
insertion 
Hypospadiasis (5) 
Appendicitis 
Ureter 
reimplantation 
Colon resection 
Port-a-cath 
insertion 
 
Tenkhoff-catheter 
insertion 
Hirschprung’s 
disease  
Appendicitis (2) 
Pancreatitis 
Peritoneal 
adhesions 
Ventilation (VT ml/kg)  
Median and Range 
8.2 
6.4 - 9.9 
8.9 
 5.5 - 12.2 
8.9 
 5.5 - 12.2 
 
 
3.2. Methods 
Each patient in the study underwent general anaesthesia during the surgical intervention. 
Anaesthesia was induced with intravenously administered midazolam, fentanyl and 
ketamine or propofol. In order to establish optimum conditions for the endotracheal 
intubation, muscle relaxants (rocuronium or cisatracurium) were applied, and the level of 
muscle relaxation was monitored by an accelerometer throughout the procedure.  
In the selection of the proper size of the intratracheal tubes, we followed the 
recommendations of internationally accepted guidelines (62). Seventeen of the examined 
patients were younger than 8 years, and they were therefore intubated with uncuffed tubes. 
In the case of the 8 patients older than 8 years, cuffed intratracheal tubes that could be 
passed with ease were inserted, but an important restriction was to have only minimally 
allowable gas leakage on ventilation. 
During the surgical intervention, the patients were ventilated via a paediatric closed 
breathing circuit by a Dräger Julian ventilator (DrägerwerkAG, Luebeck, Germany) and 
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for anaesthesia maintenance constant flow of a mixture of O2, N2O and sevoflurane was 
administered.  
CO2 samples for determination of PETCO2 could be delivered at the gas-sampling port of 
the endotracheal tube adapter in infants smaller than 4 kg, or at the CO2 sampling port of 
the airway filter interconnecting the endotracheal tube and the breathing circuit in patients 
larger than 4 kg.  
Samples for PgCO2 measurement were delivered by Boda balloonless gastric tonometric 
probes after a 10-minute equilibration period (Fig. 2). The examination tools were 
introduced nasally in every case, because of the need for firm fixation during the surgical 
procedures. The correct gastric positions of the probes were confirmed by the correct CO2 
curves on the capnograph monitor following the 10-minute equilibration period. For the 
determination of PETCO2 and PgCO2, the same equipment was used (Sidestream Microcap 
Handheld Capnograph, Oridion Medical Ltd, Jerusalem, Israel).  
In 6 cases, simultaneously with the PETCO2 and PgCO2 measurements, arterialized capillary 
blood samples were obtained for blood gas analysis. The PCO2 content of arterialized 
blood samples was determined with an ABL700 instrument (Radiometer, Copenhagen, 
Denmark). 
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Description of the gastric tonometric probes  
Figure 2 Boda's original balloonless gastric tonometric probe  
The new tonometric tool is made of silicone, 
which is highly permeable for CO2. Two 
tubes (a thicker and a thinner one) are sealed 
adjacent to each other over their full length, 
and are connected to form an uninterrupted 
tube, free of any kind of balloon. The larger 
diameter tube (A) has a lumen diameter of 2 
mm and a wall thickness of 0.25 mm, while 
the lumen diameter of the thinner tube (B) is 
0.8 mm and the wall thickness is 0.2 mm.  
The two tubes can communicate only at the 
distal end of the probe. At the proximal end 
of the device, the two tubes are held together 
with a silicone rubber fastening ring. The 
probes applied in the studies were 25 or 30 
cm in length between the fastening ring and 
the tip of the device. The well-lubricated 
probe can be inserted orally or nasally into 
the stomach in its full length up to the 
fastening ring with the aid of a similarly 
lubricated guide wire. For the purpose of 
lubrication, a symethicon emulsion 
(Espumisan , Berlin-Chemie AG, Berlin, 
Germany) is recommended. The medium 
initially fillings the probe is usually room air. The room air in the probe equilibrates with 
the environmental PCO2 of the body cavity throughout its full length within 10 minutes. 
After an equilibration period of 10 minutes, the tubing is connected to the 
microcapnograph for transport of the gaseous examination material and measurement of its 
PCO2. Measurements can be performed repeatedly at intervals, as desired. Repeated 
measurements of the PCO2 content at stated intervals and storage of the data can also be 
carried out through use of an automated monitoring device. 
18 
 
Improved types of probes combined with a built-in gastric catheter make another 
nasogastric catheter unnecessary, which is more convenient for the patients. 
Use of the probe in humans was approved by the Ethical Committee of the Hungarian 
Academy of Sciences and the Human Investigation Review Board of the University of 
Szeged. 
 
3.3. Statistical analysis 
The relationships between the measured PETCO2 and PgCO2 in the study groups were 
examined by linear regression analysis. Pearson’s correlation coefficient and p values were 
also calculated. To examine the agreement between the measurements, Bland - Altman 
analysis (63, 64) was performed.
 
The bias (defined as the mean difference between values), 
the precision (defined as the standard deviation (SD) of the bias) and the limits of 
agreement (defined as the bias ± 2 SD) were determined for the groups.  
Since there were multiple measurement data from each patient for the various PCO2 
values, we used a two-way mixed-model repeated-measurements analysis of variance 
(ANOVA) with groups as between-subject factor and time as within-subject factor for the 
comparison of the different groups. This method is a generalization of the two-sample t-
test, where both group differences and the individual within-subject variations in time can 
be modelled.  
SPSS 15.0 for Windows (SPSS for Windows Rel. 15.0, SPSS Inc., Chicago, Illinois, USA) 
was applied for the statistical calculations. 
 
4. STUDY 2 
In the second prospective study, 2 groups, 44 ventilated NICU patients in different 
severities of their disease, were enrolled. 
4.1. Patients 
The 35 NICU patients in group 1 were in a severe but stable condition, with clinical risk 
index for babies (CRIB) scores ≤ 10, while group II consisted of 9 patients with severe 
illness (CRIB scores > 10). Details of these patients and their diagnoses are given in Table 
2. 
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Table 2 Characteristics of the examined NICU patients 
Parameters 
Group 1 
(CRIB scores ≤ 10, 
n = 35) 
Group 2  
(CRIB scores > 10, 
n = 9) 
Age Gestational age at birth  
[weeks ± SD] 
32.1 ± 3.7 30.9 ± 6.9 
Age at the time of examination  
[days ± SD] 
11.9 ± 16.2 12.3 ± 11.14 
Weight 
[g ± SD] 
 
1833 ± 885 1871 ± 1281 
Diagnoses Prematurity with sepsis 5 3 
 + RDS + NEC 2 - 
+ RDS + pulmonary 
haemorrhage 
1 - 
Prematurity with RDS 11 2 
+ Ptx 1 - 
+ IVH (grade II) 1 - 
+ PDA 3 - 
+ Infant of mother with DM 1 - 
Persistent foetal circulation   
+ Ptx 1 - 
+ RDS + VSD + Down sy. 1 - 
Meconium aspiration 
syndrome 
2 - 
Post-cardiac surgery care   
 VSD (PA banding) 1 - 
 CAVC defect (PA banding) - 1 
 Coarctation of aortic arch - 1 
Other anomalies   
 Biliary atresia 1 - 
 Infection + convulsions 1 - 
 Perinatal hypoxia 3 - 
 Short rib syndrome - 1 
 Glycogenosis + hypoxia - 1 
CRIB score 
(mean ± SD) 
 
3.54 ± 2.3 12.25 ± 2.17*** 
 
There was significant difference between the two groups (Student’s unpaired t-test) in terms of their CRIB 
scores (***p < 0.001),   
CAVC, complete atrioventricular canal; IVH, intraventricular haemorrhage; PA, pulmonary artery; PDA, 
persistent ductus arteriosus; Ptx, pneumothorax; VSD, ventricular septal defect. 
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4.2. Methods 
The patients were investigated throughout their full stay in the NICU. Each of them was 
ventilated and sedated to meet their demands. For the determination of the sizes of the 
uncuffed tubes to be used for intratracheal intubation, we followed the recommendations of 
internationally accepted guidelines (62), in accordance with gestational age and body 
weight, similarly as in study 1.  
The observed neonates were ventilated with SLE 2000, SLE 2000 HFO or SLE 5000 
ventilators in conventional modes (synchronized intermittent mandatory ventilation and 
continuous mandatory ventilation) according to the requirements of their conditions. The 
need for other types of ventilation, such as high-frequency oscillation, was a criterion for 
exclusion from the study. The patients involved in the study were assigned to one or other 
of two groups. The 35 neonates (all survivors) with their CRIB scores lower than 10 were 
delegated to group 1, while group 2 consisted of 9 patients in severe condition with CRIB 
scores higher than 10 (2 out of 9 survived). 
The treatment followed the local protocols, but the routine administration of H2 receptor 
blockers was omitted. Three types of PCO2 measurements were made in each patient, the 
ventilator setting parameters remaining unchanged. 
PETCO2 was measured on samples obtained from the gas-sampling port of the intratracheal 
tube adapter. Each measurement lasted for at least 4 minutes and the highest measured 
value was accepted. PETCO2 was measured with a Sidestream Microcap Handheld 
Capnograph (Oridion Medical Ltd, Jerusalem, Israel).  
PgCO2 levels were examined with the use of Boda’s gastric tonometric probes, inserted 
orally or nasally. To ease the introduction, a flexible guide wire was used in the probe. 
Both were well lubricated with symethicon. The positions of the probes were considered 
gastric if correct CO2 curves were obtained on the capnograph monitor after the 10-minute 
of equilibration period. Gastric tonometric measurements were performed after the 
appropriate equilibration interval had passed, and measurements were also made with the 
Sidestream Microcap Handheld Capnograph. 
The acid-base parameters (pH, HCO3
-
, BE, PO2 and PCO2) were obtained from the blood 
gas analysis of umbilical artery blood samples or arteriolized capillary blood samples with 
an ABL 700 instrument (Radiometer, Copenhagen, Denmark). 
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Two more data were calculated from the results of the measurements: the Pg-aCO2 gap and 
the Pg-ETCO2 gap. The dead-space ventilation fraction was estimated via the equation: 
dead-space volume / tidal volume = (Pa-ETCO2) / PaCO2.  
 
4.3. Statistical analysis 
As there were multiple measurement data from each patient for the various PCO2 values, 
we used a two - way mixed - model repeated - measurements ANOVA for the comparison 
of the two groups.  For the comparison of the PCO2 gap values in the groups, a three-way 
mixed-model ANOVA was used, with the groups as between-subject factor, gaps as 
within-subject factor and time as within-subject factor. The various PCO2 values and PCO2 
gap values were compared using Bland - Altman analysis for multiple measurements per 
individual, and the correlation recommended for repeated measurements was used for the 
comparison of the characteristics of the neonates in the two groups of patients with 
unpaired Student’s t-tests. 
 
5. RESULTS (in the sequence of the main questions studied) 
Result I 
Study 1.  Apart from 2 cases, the gastric tonometric probes could be introduced with ease. 
In one case, the probe stopped at a certain point of the oesophagus and could not 
be passed further. In the other case, the probe could not be passed through the 
pharynx. There were no further technical difficulties during the measurements. 
Study 2.  The oral or nasal introduction manoeuvres of the tonometric probes proved facile 
in all cases. There were no difficulties, unintended side-effects or serious 
complications during the introduction procedure or the repeated measurements. 
 
Result II 
Study 1. In spite of the differences between the ages of the group I and II patients, their 
PETCO2 levels were nearly identical (mean difference 0.10 mmHg and p = 0.96), 
whereas the result in group III differed significantly from those for the elective 
surgery cases (mean differences: 1.9 mmHg and 2.0 mmHg, p = 0.03 and 0.031, 
respectively). 
When groups I and II were combined, their PETCO2 levels differed significantly 
from that for group III (mean difference 1.94, p = 0.014) (Table 3).  
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Table 3 Number of measurements, measured CO2 levels and calculated Pg-ETCO2 gaps of 
the three groups in study 1. 
 Group I 
(elective surgery 
group < 2 years 
old, n = 10) 
Group II 
(elective surgery 
group > 2 years 
old, n = 9) 
Group III 
(acute surgery 
group, 
n = 6) 
Number of measurements 42 34 32 
PETCO2 (mmHg) 
mean ± SD 
34.19 ± 3.95 34.09 ± 2.85 36.09 ± 3.87  
PgCO2  (mmHg) 
mean ± SD 
40.31 ± 4.73 39.46 ± 3.56 48.12 ± 5.93  
Pg-ETCO2 (mmHg) 
mean ± SD 
6.12 ± 3.9 5.37 ± 2.48 12.03 ± 5.67  
Significant differences between the data forgroup III and the pooled data for groups I + II regarding PETCO2, 
PgCO2, and Pg-ETCO2 values ( p < 0.05; and  p < 0.001). 
 
Study 2. There were no significant differences in PETCO2 between the groups of NICU 
patients with conditions of different severity, nor when either group I or group II 
was compared with the overall group (p = 0.05) (Table 4).  
Table 4 Comparison of PETCO2, PgCO2, PaCO2, Pg-ETCO2 gap and Pg-aCO2 gap values in 
the different groups of NICU patients in study 2 
Parameters Group 1 
(n = 35) 
Group 2 
(n = 9) 
All patients 
(n = 44) 
PETCO2 (mean ± SD) 36.53 ± 6.65 36.41 ± 5.75 36.51 ± 6.47 
PgCO2 (mean ± SD) 46.45 ± 8.13 54.68 ± 13.7* 47.91 ± 9.81 
PaCO2 (mean ± SD) 43.92 ± 8.22 45.97 ± 8.81 44.29 ± 8.33 
Pg-ETCO2 gap (mean ± SD) 9.92 ± 6.2a 18.27 ± 10.49**,a 11.4 ± 7.79a 
Pg-aCO2 gap (mean ± SD) 2.53 ± 6.78 8.71 ± 10.89* 3.63 ± 7.98 
Number of parallel 
examinations 
(median[min–max]) 
3 (1 – 10) 3 (1 – 4) 3 (1 – 10) 
 
Between-group values were compared with a mixed - model repeated - measurements ANOVA, while the 
two gap values of the same patients were compared with Student’s paired t-tests. Significance was taken as a 
p < 0.001 in the case of the paired t-tests and *p < 0.05, **p < 0.01 in the case of mixed - model repeated - 
measurements ANOVA tests.  
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Result III 
Study 1.  Arterialized capillary blood samples were taken simultaneously with the PETCO2 
and PgCO2 measurements under intraoperative circumstances in only 6 cases. In 
these cases, the average ± SD of the differences between the arterialized blood 
and end-tidal CO2 value was 2.38 ± 2.23 mmHg. The difference between the two 
parameters was statistically not significant (p = 0.35) (Table 3). 
Study 2. In each group of examined NICU patients, PETCO2 proved to be lower than 
PaCO2. There was a significant correlation (p < 0.001) between each pair of 
PaCO2 and PETCO2 (r = 0.631). This correlation did not reveal a closer 
connection than that found between the gastric and systemic PCO2 levels. The 
various PCO2 and gap values are detailed in Table 4. 
 
Result IV 
Study 1.  The fraction of dead-space ventilation was not calculated during this study. In the 
6 intraoperative cases where simultaneous arterialized capillary PCO2 
measurements were performed, the average ± SD of the differences between 
PETCO2 and PaCO2 was 2.38 ± 2.23 mmHg (not statistically significant: p = 
0.35). 
Study 2.  In the low body weight NICU patients, a dead-space of 0.176 ± 0.223 was 
observed. The dead-space was significantly higher in group 2 (0.236 ± 0.098 
versus 0.155 ± 0.143, p = 0.022). We also compared the smaller (weight < 1500 
g, n = 13) and larger (weight > 2500 g, n = 15) patients. In this comparison, the 
dead-space was higher in the case of the low birth weight neonates (0.194 ± 
0.115 versus 0.146 ± 0.141), but the difference was non-significant (p = 0.069). 
In each NICU patient group, the PETCO2 was significantly lower than PaCO2, and 
as a consequence the Pg-ETCO2 gap was significantly higher than the Pg-aCO2 
gap. In the cases of PgCO2 and both gaps, there was a significant difference 
between groups 1 and 2. 
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Result V  
Study 1. We obtained nearly identical PgCO2 values in groups I and II (mean difference 
0.85 mmHg, p = 0.45), but the corresponding result in group III of acute patients 
differed significantly from those for the elective surgery cases (mean differences 
7.8 mmHg and 8.66 mmHg, p < 0.001 and p < 0.001, respectively). When 
groups I and II were combined, their PgCO2 level differed significantly from that 
for group III (mean difference 8.81, p < 0.001 (Table 3). 
Study 2.  PgCO2 was significantly higher in group 2 of severely ill NICU patients than in 
group 1, consisting of children in a better health state (p < 0.05).  The data are 
detailed in Table 4. 
 
Result VI 
Study 1.  In the course of the study simultaneous arterialized capillary PCO2 sampling 
could be performed in only 6 of the total of 25 cases. The differences between 
the Pg-aCO2 values of the investigated groups could not be evaluated because of 
the low number of data.  
Study 2.  Pg-aCO2 was significantly higher in group 2 (NICU patients in a more severe 
condition) than in group 1 (NICU patients with a better disease status) (p < 0.05) 
(Table 4). 
 
Result VII 
Study 1.  Although PETCO2 was higher in group III, Pg-ETCO2 was still greater in the group 
of acute patients than in groups I and II. This difference proved to be significant 
(p < 0.001) (Table 3).  
As the data for the two elective surgery groups did not differ significantly, Bland 
- Altman analysis was performed on the combined data for groups I and II, while 
the acute surgery cases were analysed separately (Fig. 3A and 3B). 
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Figure 3A  Bland - Altman analysis of the data on elective surgery cases (groups I + II). 
 
 
 
 
 
 
 
 
 
Bias = 5.79, precision = 3.14, limits of agreement -1.04 to 12.62. 
 
Figure 3B Bland - Altman analysis of the data on acute surgery cases (Group III) 
   
 
 
 
 
 
 
 
 
 
 
Bias = 12.03, precision = 5.67, limits of agreement 0.68 to 23.37. 
 
The comparison of the bias values between the elective surgical groups and the 
acute surgical group (i.e. the Pg-ETCO2) revealed a significant difference (p < 
0.001). Significant correlations were found between PgCO2 and PETCO2 in each 
group (group I: r = 0.59, p < 0.001; group II: r = 0.71, p < 0.001; group III: r = 
0.39, p < 0.029). 
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Study 2.  In each NICU patient group, PETCO2 was significantly lower than PaCO2, and as a 
consequence, the Pg-ETCO2 gap was significantly higher than the Pg-aCO2 gap. 
PgCO2 and the Pg-ETCO2 gaps were significantly higher in group 2 (p < 0.01). 
The various PCO2 gap values are reported in Table 4.  
 
Result VIII 
Study 1. Since the Pg-aCO2 gap could not be calculated as a result of the inappropriate 
number of arterialized capillary blood samplings, the correlations between the 
Pg-aCO2 gap and Pg-ETCO2 gap for the various groups could not be established. 
Study 2. There was a significant correlation (p < 0.001) between the Pg-aCO2 gap and the 
Pg-ETCO2 gap (r = 0.635). During the examination of the relation of the two 
PCO2 gaps, Bland - Altman analysis (Fig. 4A and 4B) revealed an acceptable 
correspondence between the two methods (7.78 ± 6.34 mmHg, bias and 
precision). 
 
Figure 4A Correlation (calculated with a method recommended for repeated 
measurements) of the Pg-aCO2 gap and the Pg-ETCO2 gap in neonates.  
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Figure 4B Bland - Altman analysis of the Pg-aCO2 gap and the Pg-ETCO2 gap values in 
neonates 
 
.  
 
Result IX 
Study 1.  The Pg-ETCO2 gap in group I of elective surgical patients younger than 2 years 
was 6.12 ± 3.9, and in group II, the elective surgical cases older than 2 years, 
was 5.37 ± 2.48. The Pg-ETCO2 gap was significantly higher (12.03 ± 5.87) in 
group III of acute surgical patients. 
Study 2. The Pg-ETCO2 gap for group 2, NICU patients with a worse health status, 
significantly exceeded that for group 1, NICU patients in a better condition (8.71 
± 10.89 and 2.53 ± 6.78, respectively). 
 
6. DISCUSSION 
CO2 is a very important and measurable end-product of the cellular metabolism. The 
measurement and continuous monitoring of the blood PCO2 content and PETCO2 in the 
exhaled gas are considered standard monitoring techniques providing important 
information about the global circulatory, respiratory and metabolic conditions of patients. 
Nevertheless, circulation disturbances caused by diseases, sepsis or shock can be hidden in 
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the early stage of onset if the overall CO2 production is monitored alone. Early 
redistribution of the circulation in order to maintain the functions of the vital organs causes 
a reduction of gut perfusion with a concomitant increase in local CO2 production in the 
splanchnic area. Gastric tonometric measurement of the gut tissue PCO2 has been widely 
used for the detection of a deterioration of the splanchnic blood supply as an early sign of 
shock and multiorgan failure, either in intensive care or in the perioperative period of 
surgery (29, 65).   
However, technical difficulties emerged with gastric tonometric measurements in children 
and infants. Up to the start of our studies, there had been only a few reports in the literature 
concerning trials of gastric tonometric measurements in small paediatric populations (50 - 
52, 59, 66, 67). The most vulnerable point of paediatric tonometry was the limitation of 
applicability in the population of small patients, caused by the thickness of the adult tube 
and the relatively large size of the inflatable balloon. There have been studies in children 
when, in the lack of gastric tonometric probes of appropriate size, small-bore adult gastric 
tonometric probes, or adult-type sigmoid tonometric tools were applied. Sigmoid 
tonometers used to measure sigmoid mucosal pHi in adults are much smaller than adult 
gastric tonometers. In spite of the favourable experiences with the use of adult sigmoid 
tonometers in paediatric gastric tonometric investigations, it has been emphasized that a 
much smaller device would be needed for neonates and prematures (51, 52). 
The problem could be solved by the development of a new, balloon-free type of tonometric 
probes for paediatric patients of any age. The suitability of Boda's gastric tonometric probe 
in both adults and the paediatric population has already been extensively studied and 
proven (15 - 20).   
As a step in the validation studies, we demonstrated the feasibility of the procedure with 
the new tool in children undergoing surgery in study 1. Furthermore, we wished to extend 
its use to the intraoperative control of anaesthetized children through utilization of the 
Pg-ETCO2 gap. As far as we know, before the start of our study there had been only one 
report on an examination of the reliability of the intraoperative PgCO2 - PETCO2 difference 
in children (68). In study 2, we examined the new probe in very small patients in a severely 
ill condition and assessed the importance of the Pg-ETCO2 gap in neonates, since we are not 
aware of any other report on this question in the literature. 
From a technical point of view, the Boda probes proved to be well applicable both in 
intensive care and under intraoperative circumstances. In study 1, the well-lubricated 
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tonometric probes could be introduced with ease in all but 2 cases. In one case, the probe 
stopped at a certain point of the oesophagus and could not be passed further. This probe 
had to be removed, but could easily be replaced by another one. In the second case, the 
probe could not be passed through the pharynx, probably for anatomical reasons, and the 
help of Magill forceps was needed. There were no further complications or technical 
difficulties during the measurements. The minimally invasive probe can be introduced 
orally or intranasally. In anaesthetized patients, intranasal insertion proved to be more 
useful because the limited approach in the small patients during surgical interventions 
required firm fixation of the probe. The facile insertion of the tool could be further 
enhanced by the use of a thin and flexible guide-wire; both should be thoroughly lubricated 
with a symethicon (Espumisan
®
) emulsion. In the NICU patients in study 2 the probes 
could be inserted orally or nasally into the stomach in a problem-free way. There were no 
difficulties, unintended side-effects, or serious complications during the introduction 
procedures or the repeated measurements. 
After the short equilibration time, the performance of the measurements was simple. Since 
the initial studies, the problems of automated measurement, the analysis of PgCO2, storage 
of the measured data and the technical errors caused by either interoperator variability or 
handling of the gas samples have been solved and the monitoring apparatus is available. 
Further studies by Boda (publication in preparation) demonstrate that the otherwise short 
time needed for equilibration of the gases in the probe can be appreciably decreased by 
using higher concentrations of CO2 in air as filling medium. Accordingly, extended use of 
the balloonless gastric tonometric probes in general clinical practice, and particularly in 
paediatrics, may be highly recommended. 
The patients examined in the two studies did not receive antacid medication or H2-receptor 
antagonists on a routine basis. The gastric CO2 generated by the neutralization of gastric 
acid by duodenal HCO3
-
 may disturb the measurement of the gastric pH. The use of H2-
receptor antagonists to reduce the production of gastric acid before tonometric 
measurement appears reasonable, though it has been debated in small children. The 
literature on the development of the gastrointestinal tract of premature neonates underlines 
the various degrees of immaturity of the stomach. The intragastric pH in very low birth 
weight neonates within the first 48 hours of life is about 5.5-7.0. Campbell and Costeloe 
found lower pHi values (pHi = 7.27 ± 0.078) in very low birth weight neonates than the 
values previously reported in children (50). Gastric emptying also proved to be slower in 
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premature neonates than in term infants. Furthermore, many patients are not fed by enteral 
food for several days, with a resultant high gastric pH, and H2-receptor antagonists are 
often administered in order to decrease gastric acid secretion. The lower gastric capacity of 
H
+ 
production of prematures is one of the weak points of the defence against ingested 
pathogens and toxins. Further reduction of the already low gastric juice production by the 
use of H2-receptor antagonists is associated with a higher incidence of greater bacterial 
translocation, nosocomial sepsis and gastrointestinal diseases such as NEC (69). Since 
neutralization of the otherwise lower amount of gastric acid in prematures can be harmful, 
while Calvet and his colleagues found that the administration of ranitidine does not affect 
the variables of pHi in critically ill patients (70), the routine administration of H2-receptor 
antagonists in gastric tonometric measurements would raise ethical questions, and it is not 
recommended in this age group.  
Thre parameters PETCO2, PaCO2 and PgCO2 were measured in our studies; the Pg-aCO2 and 
Pg-ETCO2 were then calculated and compared.  
Capnometry is a routine, non-invasive monitoring method for the continuous evaluation of 
PETCO2 in patients, including those in paediatric care. Nevertheless, the acquisition of 
reliable PETCO2 values in small patients may encounter difficulties. The higher respiratory 
rate of small tidal volumes, the considerable air leakage on ventilation, the relatively long 
distance between the site of gas exchange and the sampling port and the sometimes 
enlarged respiratory dead-space may result in an apparent reduction of PETCO2. In our 
small patients, we srived to minimize the bias in the PETCO2 measurements through the 
application of endotracheal tubes of the correct size, the control of air leakage, the nearest 
position of the sampling port to the patient and the slower than normal speed of gas 
sampling (71). 
In the event of correct monitoring, the level of exhaled PCO2 is determined by the overall 
circulatory, respiratory and metabolic factors, the satisfactory functions of the 
compensatory buffering systems and the eliminating mechanisms. In anaesthetized and 
ventilated patients, the main determinant of PETCO2 is the efficiency of ventilation. The 
parameters of the ventilation in our patients were not determined in advance; they were 
ventilated according to their requirements in order to keep them within the limits of 
normocarbia. During the evaluation of the results of the two studies, the increase in 
PETCO2 (experienced only in the group of acute surgical patients) can be explained mostly 
by the position of the patients and the site of the surgery. All of these relaxed patients were 
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operated on in the supine position, and the increased intrathoracic pressure caused by the 
transmission of the elevation of the abdominal pressure due to the surgical manipulation 
decreased the efficiency of the pressure-controlled ventilation. Some of the elective 
surgical patients were in a lateral position during the surgery, and the sites of the 
operations were usually more distant from the diaphragm. 
PETCO2 values and the extent of reflecting PaCO2 (mostly in small patients) depend 
considerably on several factors, such as the site and the type of gas sampling (main-stream 
or side-stream capnography), the speed of gas sample suction (71), the seal of the 
endotracheal tube and the extent of dead-space ventilation caused by an increased 
ventilation/perfusion mismatch. Higher dead-space ventilation can be caused by either a 
decreased cardiac output or a higher pulmonary pressure with right-to-left shunts. 
Decreased membrane diffusion states (RDS or Streptococcus agalactiae infection) may 
also lead to a greater difference between the PaCO2 and PETCO2 levels. In these cases, 
PETCO2 may underestimate PaCO2. The results of study 2 demonstrated this phenomenon 
well, when PETCO2 was significantly lower than PaCO2 in all groups of NICU patients; the 
lower PETCO2 may arise from the high proportion of respiratory dead-space caused by the 
small weight and small tidal volumes. Higher pulmonary arterial pressure may cause right-
to-left shunts (through the foramen ovale and patent duct) and may further increase the 
functional dead-space. We presume that the difference between PgCO2 and PETCO2 reflects 
the difference between PgCO2 and PaCO2. 
Several studies have emphasized the good correlation at a given patient status between 
PaCO2 and PETCO2, not only in adults (72), but also in children and neonates (73 - 75). In 
study 2, we also found highly significant, acceptable correlations between the two systemic 
PCO2 levels, and consequently between the two systemic-gastric PCO2 gaps.  
Numerous studies and reviews have revealed that an elevation in PgCO2 may be an early 
indicator of an impairment of the splanchnic circulation and hence a worsening condition 
of the patient (11). Similarly, we found a significantly higher PgCO2 in the group of acute 
surgical patients than in the two groups of elective surgical patients in study 1. In study 2, 
PaCO2 and PgCO2 in the group of severely ill NICU patients (group 2) were also in excess 
of the corresponding data in group 1 (NICU patients in better condition). 
In order to allow further distinctions between local hypoxia and generalized acidosis on the 
basis of the results of gastric tonometry, monitoring of the PCO2 gap (the difference 
between the tonometric and arterial PCO2) is recommended. On the assumption that the 
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PaCO2 – alveolar PCO2 difference is constant (normally 4 mmHg = 0.5 kPa), the Pg-ETCO2 
gap, a minimally invasive marker of gastric perfusion, can also be applied during 
evaluation of the tonometric findings (30). Only very limited data are available on 
simultaneous intraoperative measurements of PETCO2 and PgCO2 in children (68), and we 
are not aware of studies that have evaluated the Pg-ETCO2 gap in neonates. We found that, 
imilarly as in adults, both intraoperative and intensive care monitoring of PETCO2 and 
PgCO2 can be performed in children and in neonates, and even in prematures. The great 
advantage of Pg-ETCO2 gap is that it may reflect the adequacy of gastric mucosal perfusion. 
If it is monitored, perfusion abnormalities, and hence changes or redistribution of the 
circulation, may be noticed promptly (even in an early phase of shock, often when the 
systemic haemodynamics is stable). Our study under paediatric surgical circumstances 
revealed significantly increase of Pg-ETCO2 gap values in group of acute surgical patients, 
and in study 2 the Pg-ETCO2 gap (similarly to the Pg-aCO2 gap) proved to be significantly 
higher in severely ill neonates. We also found that in low body weight NICU patients the 
Pg-ETCO2 gap overestimated the Pg-aCO2 gap. This disagreement between the two gaps may 
result from the difference between the simultaneously obtained PaCO2 and PETCO2 values, 
explained above. Our results on neonates did not indicate any larger SD (precision) 
between the two gap values, as reported by Uusaro et al. in the case of adults (76). 
Although this SD is not negligible, we consider that the agreement between the two 
methods is acceptable and allows use of the Pg-ETCO2 gap in clinical practice as a 
semicontinuous indicator of the adequacy of the splanchnic circulation. 
The use of the Pg-ETCO2 gap instead of the Pg-aCO2 gap makes arterial blood gas analyses 
unnecessary, which is of particular importance in the case of the paediatric population. 
Measurement of the Pg-ETCO2 gap is convenient: it does not require a laboratory 
background, and the problems caused by sample handling can be eliminated.  
Conventional gastric tonometric parameters are well applicable for prediction of the 
outcome in paediatrics (65). Krafte-Jacobs et al. reported pHi = 7.32 ± 0.18 in non-
surviving and pHi = 7.48 ± 0.07 in surviving seriously septic children treated in an 
intensive care unit (66). The Pg-ETCO2 gap is also considered a prompt and sensitive 
indicator of the adequacy of the splanchnic circulation, even in an early phase. A 
multicentre study has revealed that a higher value of Pg-ETCO2 obtained intraoperatively 
may serve as a predictor of a postoperative functional recovery delay (34). Our observation 
of study 2 that children in more severe condition gave higher Pg-ETCO2 gap data may 
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indicate that the splanchnic perfusion was partially impaired. Although there may be 
disagreement between the conventional PCO2 gap and the Pg-ETCO2, this has been 
suggested not to be important clinically, and the Pg-ETCO2 gap may be regarded as a 
suitable parameter for the continuous estimation of splanchnic perfusion (76). 
However, our studies involve several limitations. In spite of the low number and 
heterogeneous group of patients without randomization, study 1 demonstrated that this 
method is suitable for routine intraoperative monitoring in children, infants and neonates, 
but further randomized studies are needed on a larger population of patients. Furthermore, 
arterial samples for PaCO2 determination may have been necessary, but for ethical and 
technical reasons indwelling arterial catheters could not be inserted, and in the given 
circumstances, the data from the measurements with the arterialized capillary technique did 
not correspond to strict criteria. It is an obvious problem with the Pg-ETCO2 gap that in 
neonates with impaired gas exchange, PETCO2 does not represent PaCO2 (PETCO2 may 
underestimate PaCO2). However, there are at least three reasons why the potential 
overestimation of the gastric-systemic PCO2 difference is not a major clinical problem. 
First, if there is a wide Pg-ETCO2 gap, the Pa-ETCO2 gap may be measured and used to 
interpret the Pg-ETCO2 gap. Secondly, an overestimate of a gastric-systemic PCO2 
difference means that truly increased PCO2 differences will not be left undetected. Thirdly, 
if the gastric-systemic PCO2 differences in each neonate are compared with their own gaps, 
the widening of the gap values will be noticed and therapeutic interventions can be 
performed earlier. 
As a summary, with some limitations, monitoring of the Pg-ETCO2 gap via application of 
the balloonless paediatric gastric tonometric probes can almost certainly be recommended 
in paediatric care, even for the smallest patients and in wide-ranging fields. However, 
further examinations should be performed, and randomized clinical studies are needed to 
assess the predictive role of the method. 
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7. CONCLUSIONS (in the sequence of the main questions studied) 
Conclusion I  
Boda’s novel gastric tonometric probe is a useful tool in the care of the smallest patients. It 
can reform gastric tonometric monitoring, and enhances the safety of paediatric and 
neonatal care under a broad range of circumstances. For these reasons, introduction of the 
device in everyday paediatric and neonatal monitoring practice is strongly recommended. 
 
Conclusion II 
Changes in end-tidal CO2 levels did not seem to be dependent on age or the severity of the 
condition in our ventilated patients. In spite of the individully set ventilatory strategy, an 
elevation in PETCO2 was found only in the acute surgical group of patients. The 
phenomenon could be explained only by external physical effects on the patients. 
Nonetheless, all ventilated patients should be monitored by continuous capnometry, and 
particulary those who are most susceptible to undergo rapid changes in their condition, or 
who are exposed to external stimuli. PETCO2 monitoring indicates the effectiveness of 
ventilation, providing prompt warning sign of abrupt changes in the condition of the 
patient and furnishing the opportunity for other monitoring techniques, leading to more 
specific information on the patients’ condition.  
 
Conclusion III 
In each group of examined NICU patients, PETCO2 proved to be lower than PaCO2, though 
PaCO2 and PETCO2 correlated significantly in the examined ventilated NICU patients. With 
the excepcion of certain circumstances, there is a good correlation between the 
concomitant PaCO2 and PETCO2 values in paediatric patients. In these cases, PETCO2 
monitoring is a pain-free, blood-sparing and non-invasive way to estimate PaCO2. 
However, blood gas sampling can not be omitted. Rapid and excessive changes or an 
irregular tendency of PETCO2 are indications of the need for PaCO2 control. 
 
Conclusion IV 
Higher dead-space was calculated in the group of NICU patients in a more severe 
condition, and a non-significantly increased dead-space was found in the low birth weight 
neonates. Higher dead-space ventilation due to physiological developmental reasons or 
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diseases leads to a greater difference between PaCO2 and PETCO2, consequently giving rise 
to a divergence between the Pg-aCO2 and Pg-ETCO2 gaps. 
 
Conclusion V 
Significantly higher PgCO2 values were obtained in the acute surgical patients in the first 
study; similarly, higher PgCO2 results were found in group 2 of severely ill NICU patients. 
An elevation in PgCO2 may be a warning sign of a severe condition of paediatric patients 
or it may suggest an imminent worsening of their health status. In order to acquire more 
accurate information concerning the condition of the patient, evaluation of either the 
Pg-aCO2 gap or the Pg-ETCO2 gap is required. 
 
Conclusion VI 
The differences between the PgCO2 and PaCO2 values of the different groups could be 
evaluated only in study 2. In terms of the Pg-aCO2 gap, there was a significant increase in 
group 2, comprising NICU patients in a more severe condition, as compared with the 
patients in better health. This provides support for the finding that widening of the Pg-aCO2 
gap is a good indicator of the severity of the splanchnic impairment and hence the 
worsening of the disease. 
 
Conclusion VII 
In study 1, the difference between PETCO2 and PgCO2 was significantly greater in the 
group of acute patients, and in study 2 the Pg-ETCO2 gap was significantly higher in group 2 
of severely ill patients. We found that monitoring of the Pg-ETCO2 gap, similarly to 
monitoring of the Pg-aCO2 gap, provides a useful and sensitive indication of a splanchnic 
impairment and hence the worsening of the patient’s condition. This method is more 
convenient, and causes no pain and blood loss as compared with monitoring of the Pg-aCO2 
gap. 
 
Conclusion VIII 
The potential correlation between the Pg-aCO2 and Pg-ETCO2 gaps could not be investigated 
in study 1. In study 2, we found a significant correlation between the Pg-aCO2 gap and the 
Pg-ETCO2 gap, and relation analysis of the data revealed an acceptable correspondence 
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between the two methods. This result suggests that monitoring of the Pg-ETCO2 gap can be 
an effective alternative to monitoring of the Pg-aCO2 gap in neonatal patients. 
 
Conclusion IX  
The Pg-ETCO2 gap results clearly indicates a  significant increase in the acute surgical group 
in study 1, and in study 2 it also proved to be significantly higher in the group of severely 
ill patients. Our findings tend to support the assumption that the Pg-ETCO2 gap may reflect 
the severity of the disease. 
 
8. MAJOR FINDINGS OF THE THESIS 
I. The clinical utility of Boda balloonless gastric tonometric probes under paediatric 
intraoperative circumstances was investigated for the first time in our study. It 
proved to be reliably and easily applicable in patients of different ages and with 
various surgical diseases, and the measurements provided useful information 
relating to the severity of the disease. 
II. Gastric tonometric investigation of the Pg-ETCO2 gap is also a well-applicable 
method in the course of paediatric surgical interventions and is informative as to 
the severity of the disease. 
III. This was probably the first investigation of the clinical value of the Pg-ETCO2 gap as 
compared with the Pg-aCO2 gap in low body weight prematures and neonates. 
Measurements of the Pg-ETCO2 gap with its advantages can be a good alternative to 
the Pg-aCO2 gap investigations in this population of patients, but it can not 
completely eliminate the need for occasional blood gas samplings. 
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